Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Richmond wins a Breakthrough Culture Award for committing to a people-first culture

13
March 2025

Richmond has been recognised as a great place to work and as one of the Breakthrough Culture Award winners for 2024.

View Articles

Richmond Supports Groundbreaking Study in Alpha-1 Antitrypsin Deficiency (AATD) with Beam Therapeutics

12
March 2025

Richmond congratulates Beam Therapeutics on the preliminary results from the first three dose levels of its ongoing Phase 1/2 study...

View Articles

First patient enrolled in telehealth study, the Pathway Study

25
February 2025

The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...

View Articles

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

17
February 2025

We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...

View Articles

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

10
February 2025

The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...

View Articles

Richmond trains taxi drivers to deliver lifesaving CPR

3
December 2024

Richmond has just trained a first group of taxi drivers to deliver cardiopulmonary resuscitation (CPR) aimed at saving the lives of their passengers.

View Articles

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event